MedTrace Logo

Efficacy of Oral Ibandronate in Osteoporosis

NCT03186131 · Status: UNKNOWN · Phase: PHASE2 · Type: INTERVENTIONAL · Enrollment: 100

Last updated 2021-09-21

No results posted yet for this study

Summary

There has been no comparative data between oral ibandronate and oral ibandronate plus active vitamin D

Conditions

Interventions

DRUG

Ibandronate

To examine the efficacy of oral Ibandronate in osteoporosis

DRUG

Oral Ibandronate and Vitamin D

To examine the efficacy of oral Ibandronate and Vitamin D in osteoporosis

Sponsors & Collaborators

  • Shinshu University

    lead OTHER

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
20 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2017-10-12
Primary Completion
2022-12-08
Completion
2025-06-08

Countries

  • Japan

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03186131 on ClinicalTrials.gov